A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2) - Full Text...
Urinary Bladder Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. Urinary Bladder Diseases. ... A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2). The safety ... Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer. ... Malignancies other than urothelial bladder cancer within 5 years prior to Cycle 1, Day 1, with the exception of those with a ...https://clinicaltrials.gov/ct2/show/study/NCT02108652
Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or...
Cancer. Neoplasms. Bladder. Urothelial Tract. Additional relevant MeSH terms: Urinary Bladder Neoplasms. Urologic Neoplasms. ... Urogenital Neoplasms. Neoplasms by Site. Neoplasms. Urinary Bladder Diseases. Urologic Diseases. Gemcitabine. Cisplatin. ... Gemcitabine + Cisplatin (GC) in the First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer. ... Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer (CILAB). The safety and ...https://clinicaltrials.gov/ct2/show/NCT00625664
Pazopanib and Vinflunine in Urothelial Cancer of the Bladder
Urothelial carcinoma of the bladder mostly is chemically induced and represents the second prevalent urooncological disease. ... bladder cancer. *urothelial cancer. *metastatic urothelial cancer. *advanced urothelial cancer. *Urinary Bladder Neoplasms ... Advanced Urothelial Cancer of Bladder After Failure of Platinum-containing Therapy.. * ... Therapy With Pazopanib as Add-on to Vinflunine in Patients With Advanced or Metastatic Urothelial Carcinoma of the Bladder ...http://www.knowcancer.com/cancer-trials/NCT01265940/
Gemcitabine, Cisplatin, Plus Lenalidomide as First-line Therapy for Patients With Metastatic Urothelial Carcinoma - Full Text...
Neoplasms by Histologic Type. Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Urinary Bladder Diseases ... The primary objectives of this study are (Phase 1) to determine in subjects with unresectable or metastatic bladder cancer who ... Urinary Bladder Neoplasms. Carcinoma. Neoplasms, Glandular and Epithelial. ... Urothelial carcinoma of the urinary bladder is the second most common genitourinary malignancy. Based on the results of a large ...https://clinicaltrials.gov/ct2/show/NCT01342172
Search of: Kaiser Permanente | Recruiting, Not yet recruiting, Available Studies | cancer - List Results - ClinicalTrials.gov
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer. *Carcinoma, ... Urinary Bladder Neoplasms. *Urologic Neoplasms. *(and 4 more...). *Drug: Enfortumab vedotin. Interventional. Phase 2. *Astellas ... S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer. *Stage IVA Colon Cancer ... Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer. * ...https://clinicaltrials.gov/ct2/results?term=Kaiser+Permanente&recr=Open&cond=cancer&show_rss=Y
Search of: Recruiting, Not yet recruiting, Available Studies | 'Urethral Diseases' - List Results - ClinicalTrials.gov
LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer. *Urinary Bladder Neoplasms ... A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer. *Carcinoma, ... Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma. *Bladder Cancer ... Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer. *Metastatic Urothelial ...https://clinicaltrials.gov/ct2/results?recr=Open&cond=%22Urethral+Diseases%22&show_rss=Y&sel_rss=mod14
MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers - Full Text View - ClinicalTrials.gov
Neoplasms, Nerve Tissue. Nevi and Melanomas. Neoplasms by Site. Urologic Neoplasms. Urogenital Neoplasms. Urinary Bladder ... 16-22 subjects with inoperable or metastatic (advanced) urothelial cancer, head and neck cancer, or melanoma will be treated in ... Head and Neck Neoplasms. Urinary Bladder Neoplasms. Neuroendocrine Tumors. Neuroectodermal Tumors. Neoplasms, Germ Cell and ... Urinary Bladder Cancer Head and Neck Cancer Melanoma Genetic: Autologous genetically modified MAGE A10ᶜ⁷⁹⁶T cells Phase 1 ...https://clinicaltrials.gov/ct2/show/NCT02989064
A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer - Full Text...
Neoplasms. Ureteral Neoplasms. Urinary Bladder Neoplasms. Urethral Neoplasms. Kidney Neoplasms. Carcinoma. Neoplasms, Glandular ... urothelial cancer. bladder cancer. renal pelvis cancer. ureters cancer. urethra cancer. HLA-A2 positive. HLA-A*0201/p53 aa264- ... Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Ureteral Diseases. Urologic Diseases. Urinary Bladder Diseases. ... Muscle invasive or metastatic urothelial cancer of bladder, ureters, renal pelvis, and urethra ...https://clinicaltrials.gov/ct2/show/NCT01326871?recr=Open&cond=%22Urethral+Neoplasms%22&rank=9
A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer -...
... gemcitabine in terms of disease-free survival in non metastatic muscle invasive urothelial cancer patients. ... Gemcitabine possesses its own anti-cancer activities on urothelial diseases and has a synergetic activity with cisplatin. The ... showed local control rates with bladder preservation at 5 years ranging from 40% to 65% according to the disease stage, and ... If radical cystectomy remains the standard of care for muscle invasive bladder cancer, consequences of this surgical procedure ...https://www.careacross.com/clinical-trials/trial/NCT01495676
MR imaging bladder - Sumer's Radiology Blog
... imaging is the modality of choice in imaging of urinary bladder neoplasms, and staging accuracy of MR imaging in bladder cancer ... Common metastatic sites include bone, lung, and bowel.29 Adenocarcinoma Adenocarcinoma of the urinary bladder is uncommon, ... Several factors predispose patients to bladder cancer. Cigarette smokers are 2 to 6 times more likely to develop urothelial ... Bladder cancer Bladder cancer is more common in men (male/female: 3:1) than in women. It is the fourth most common cancer in ...http://sumerdoc.blogspot.com/2004/10/mr-imaging-bladder.html
FDA Approved Drugs by Medical Condition | CenterWatch
Bladder Cancer. Tecentriq (atezolizumab) (by Genentech), Approved May 2016. For the treatment of urothelial carcinoma and ... For the treatment of advanced or metastatic urothelial carcinoma and Stage III non-small cell lung cancer ... For the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. ... Bone Neoplasm. Xgeva (denosumab) (by Amgen), Approved June 2013. For the treatment of giant cell tumor of bone ...http://www.centerwatch.com/drug-information/fda-approved-drugs/medical-conditions/B
Urology Xagena News
Cancer immunotherapy: Atezolizumab shrank tumors in patients with locally advanced or metastatic urothelial bladder cancer In ... A clinicopathologic analysis of high-grade papillary urothelial carcinoma of the urinary tract About one half of all bladder ... neoplasms are non-invasive, and in those, the histologic grade is a crucial prognosticator. Few single-Center studies have ... Metastatic urothelial bladder cancer: MPDL3280A, an anti-PDL1, shrinks tumour in 43% of patients Results from a phase I open- ...https://www.urologynews.net/?q=Bladder
Acridine Orange Summary Report | CureHunter
Breast Neoplasms (Breast Cancer) 07/01/2013 - "Indeed exposure of MDA-MB-231 and MCF-7 human breast cancer cells as well as a ... "Urinary cytology with acridine orange fluorescence is highly valuable for predicting high-grade upper urinary tract urothelial ... 01/01/1993 - "We show that metastatic breast cancer MDA-MB231 cells migrating in vitro through a Matrigel gel in a modified ... 10/01/2012 - "Evaluation of acridine orange fluorescence in exfoliative urinary cytology for diagnosing bladder carcinoma.". ...http://www.curehunter.com/public/keywordSummaryD000165-Acridine-Orange.do
Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer - Full Text View -...
Neoplasms by Histologic Type. Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Urinary Bladder Diseases ... Participants must have histologically documented metastatic or locally inoperable advanced urothelial carcinoma (bladder, ... Urinary Bladder Neoplasms. Carcinoma, Transitional Cell. Neoplasms, Glandular and Epithelial. ... Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer. This study has been ...https://clinicaltrials.gov/show/NCT01780545
Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in...
Neoplasms by Histologic Type. Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Urinary Bladder Diseases ... Both regimens are used to treat people with urothelial cancer that has spread to other organs. Both study drug regimens have ... Absence of metastatic disease on radiographic imaging. *Patients must be enrolled and able to start treatment within 90 days of ... Urinary Bladder Neoplasms. Carcinoma, Transitional Cell. Urethral Neoplasms. Kidney Neoplasms. Ureteral Neoplasms. Neoplasms, ...https://clinicaltrials.gov/ct2/show/NCT01639521?recr=Open&cond=%22Urethral+Neoplasms%22&rank=2
Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not...
Kidney Neoplasms. Ureteral Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. Urinary Bladder ... is studying how well pazopanib hydrochloride works in treating patients with or metastatic urothelial cancer or bladder cancer ... recurrent bladder cancer. stage IV bladder cancer. recurrent urethral cancer. distal urethral cancer. proximal urethral cancer ... urethral cancer associated with invasive bladder cancer. metastatic transitional cell cancer of the renal pelvis and ureter. ...https://clinicaltrials.gov/ct2/show/NCT01031875
Cytopathology | SpringerLink
... neoplasms of the urinary bladder. Am J Surg Pathol 1998;22:1435-1447.PubMedCrossRefGoogle Scholar ... Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol 2001; ... Effusion cytology of metastatic malignancy of unknown primary. Pathol Case Rev 2001;6:154-160.CrossRefGoogle Scholar ... Low grade urothelial carcinoma: Reappraisal of cytological criteria on ThinPrep. Diagn Cytopathol 2003;29:125-129.PubMed ...https://link.springer.com/chapter/10.1007/978-1-4419-6043-6_1
Urachal cancer - Wikipedia
It can involve the urinary bladder, but is not bladder cancer in the usual sense. Urachal cancer can occur at any site along ... Other rare types include urothelial carcinoma, squamous cell carcinoma, neuroendocrine carcinoma and sarcoma. Diagnostic ... invasion of the peritoneum and metastatic disease. Sheldon, C. A.; Clayman, R. V.; Gonzalez, R.; Williams, R. D.; Fraley, E. E ... "Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin". Advances in Anatomic ...https://en.wikipedia.org/wiki/Urachal_cancer
Clinical Trials Dashboard
... in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer or Metastatic Non-Small Cell Lung Cancer. A Phase 1b ... Urinary Bladder Neoplasms. *Neoplasm Metastasis. *Melanoma. Eligibility. Criteria: Inclusion Criteria:. - Willing and able to ... urothelial bladder cancer or non-small cell Lung cancer (NSCLC). NKTR-214 in combination with atezolizumab will be evaluated in ... cancer or bladder cancer. The second arm will evaluate a q3w dose regimen of NKTR-214 in. combination with atezolizumab in up ...http://clinicaltrials.bcan.org/trial/NCT03138889
Carcinoma | definition of carcinoma by Medical dictionary
... or the urinary bladder. Synonym: urothelial carcinoma. urothelial carcinoma. Transitional cell carcinoma.. carcinoma. Any ... karkinos, cancer, + -oma, tumor] Like other malignant neoplasms, carcinomas display uncontrolled cellular proliferation, ... Metastatic spreading of cancer, usually from an internal organ to the skin, to which the spreading tumor gives a red, ... This cancer may arise from cells in the kidney, urinary bladder, or lung. ...https://medical-dictionary.thefreedictionary.com/carcinoma
Michael E. Hurwitz, PhD, MD > Yale Cancer Center | Yale School of...
Urinary Bladder Neoplasms. *Kidney Neoplasms. *Medical Oncology. *Prostatic Neoplasms. *Testicular Neoplasms. Patient Care. ... in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelial Tract Whose Tumors Harbor a TSC1 ... Bladder, Other Urinary. An Open Label, Multicenter, Single Arm Phase II Study to Evaluate the Activity and Tolerability of the ... Detection of ARv7 in the plasma of men with advanced metastatic castrate resistant prostate cancer (MCRP) ...http://yalecancercenter.org/research/people/michael_hurwitz-3.profile?source=news
Search of: Bladder AND Northwestern - List Results - ClinicalTrials.gov
A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer. *Carcinoma, ... Urinary Bladder Neoplasms. *Urologic Neoplasms. *(and 4 more...). *Drug: Enfortumab vedotin. Interventional. Phase 2. *Astellas ... Oxaliplatin in Treating Patients With Metastatic Bladder Cancer. *Bladder Cancer. *Transitional Cell Cancer of the Renal Pelvis ... Docetaxel and Gemcitabine in Treating Patients With Progressive Regional or Metastatic Bladder Cancer. *Bladder Cancer ...https://clinicaltrials.gov/ct2/results?term=Bladder+AND+Northwestern&Search=Search
Cellular Apoptosis Susceptibility Protein Summary Report | CureHunter
07/01/2012 - "Presence of CSE1L protein in urine of patients with urinary bladder urothelial carcinomas.". 08/01/2012 - "CSE1L ... Neoplasms (Cancer) 07/01/2012 - "The chromosome segregation 1-like (CSE1L) protein is highly expressed in most cancers and has ... is a new marker for metastatic cancer. ". 03/31/2008 - "CSE1L/CAS, a microtubule-associated, cellular apoptosis susceptibility ... Neoplasm Metastasis (Metastasis) 01/01/2008 - "CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and ...http://www.curehunter.com/public/keywordSummaryD029563-Cellular-Apoptosis-Susceptibility-Protein.do
Campbell's Urology On CD-Rom
Management of Invasive and Metastatic Bladder Cancer Surgery of Bladder Cancer Management of Urothelial Tumors of the Renal ... Hormonal Therapy of Prostate Cancer Chemotherapy for Hormone-Resistant Prostate Cancer 1) Part XII. Urinary Lithiasis and ... Neoplasms of the Testis Surgery of Testicular Tumors Tumors of the Penis Surgery of Penile and Urethral Carcinoma 1) Part XI. ... Urothelial Tumors: Etiology, Natural History, Pathology, Detection and Staging Management of Superficial Bladder Cancer ...http://felgueroso.com/libros/28387
SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial - Full Text View - ClinicalTrials.gov
Urinary Bladder Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. Urinary Bladder Diseases. ... Histologically/cytologically proven inoperable, metastatic or recurrent transitional cell carcinoma of the urothelial tract ... SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial (SPRUCE). The safety and scientific validity of this study ... The study objectives include the determination of the antitumor effect of SU011248 in patients with urothelial transitional ...https://clinicaltrials.gov/ct2/show/NCT00578526